The largest database of trusted experimental protocols

Microtiter plate spectrophotometer

Manufactured by Agilent Technologies
Sourced in United States

The Microtiter plate spectrophotometer is a laboratory instrument used to measure the absorbance or optical density of samples contained in a microtiter plate. It is designed to quantify the concentration of various substances, such as proteins, nucleic acids, or small molecules, by measuring the amount of light absorbed by the samples.

Automatically generated - may contain errors

Lab products found in correlation

12 protocols using microtiter plate spectrophotometer

1

MTT Assay for Cell Viability Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the MTT assay, 3 × 104/mL cells were plated in 96-well plates and treated with different doses of ML2-SA1 (1–50 μM) and DOX (1–50 μM), alone or in combination. Then, 0.8 mg/mL of MTT was added to the samples and incubated for additional 3 h. After the removal of medium from the wells, the formazan crystals were dissolved with 100 µL per well of DMSO and the colored solutions were read by microtiter plate spectrophotometer (BioTek Instruments, Winooski, VT, USA). Four replicates were used for each treatment. The drug concentration that induced 50% cell growth inhibition compared with control cells (IC50) was calculated using GraphPad Prism® 5.0a (GraphPad Software, San Diego, CA, USA).
+ Open protocol
+ Expand
2

Cell Viability Assay with MTT

Check if the same lab product or an alternative is used in the 5 most similar protocols
About 3 × 104/ml untreated, siGLO or siTRPML1 glioma cells were plated in 96-well plates up to 72 h. Then, 0.8 mg/ml of MTT was added to the samples and incubated for an additional 3 h. After the removal of the medium from the wells, the formazan crystals were dissolved in 100 μl per well of dimethyl sulfoxide (DMSO), and the colored solutions were read by microtiter plate spectrophotometer (BioTek Instruments, Winooski, VT, USA). Four replicates were used for each treatment.
+ Open protocol
+ Expand
3

Synergistic Effects of Ibrutinib and Bortezomib on Multiple Myeloma

Check if the same lab product or an alternative is used in the 5 most similar protocols
A quantity of 1 × 104/mL U266 cells and 6 × 103/mL RPMI cells were plated in 96-well plates and treated with different doses of Ibrutinib (5, 12.5 and 25 µM) for 24 and 48 h alone and in combination with Bortezomib (1, 3, 6 ng/mL). At the end of the treatment, 0.8 mg/mL of MTT was added to the samples and incubated for 3 h. Medium was removed from the wells, the formazan crystals were dissolved with 100 µL/well of DMSO and the absorbance was read by microtiter plate spectrophotometer (BioTek Instruments, Winooski, VT, USA). Four replicates were used for each treatment. IC50 values, the drug concentration that induces 50% of cell growth inhibition, were calculated using GraphPad Prism® 5.0a (GraphPad Software, San Diego, CA, USA).
+ Open protocol
+ Expand
4

Cytotoxicity Assay of Recombinant NprvNeps

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro cytotoxic effects of recombinant NprvNeps was assessed as described previously [69 (link),70 (link)] with slight modifications. A Vero cell line (ECACC 88020401, African Green Monkey kidney), widely used for the assessment of the cytotoxic effects of chemicals, toxins and other substances on mammalian cells at the molecular level [71 (link)], was grown and maintained according to Ammerman et al. [71 (link)]. Microtiter plates were incubated at 37 °C in 5% CO2 for 24 h. Recombinant NprvNeps in PBS were filtered through a sterile 0.2 µm pore size syringe membrane filter and prepared at 1 µM, 5 µM, 10 µM concentrations. All NprvNep dilutions then were added to Vero cells [1:1 (v/v) in DMEM - Dulbecco’s Modified Eagle Medium] and incubated for 20 h. After cell treatment, the medium was removed by aspiration and 50 µL of DMEM with 10% resazurin (0.1 mg/mL in PBS) was directly added to each well. The microtiter plates were incubated at 37 °C in 5% CO2 for 3 h. The absorbance was read at 570 and 600 nm in a microtiter plate spectrophotometer (Biotek Synergy, Colmar, France). Phosphate-buffered saline buffer (PBS) was used as control.
+ Open protocol
+ Expand
5

Evaluating Yeast-Induced Cell Death and Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell death and/or viability induced by different WaF17.12 concentrations (1000, 5000, 10,000 yeasts cells/mL) after 24 h and 48 h was evaluated, using MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) and PI (Sigma-Aldrich, Saint Louis, U.S.A.) assays.
In MTT assay, HaCaT cells (7.5 × 105 cells/mL) were seeded into 96-well plates and co-cultured with different yeast concentrations or the vehicle (DMEM). Upon treatment, the supernatant was removed, and the cells were washed twice with PBS 1×. MTT (0.8 mg/mL) was added to the samples and incubated for 3 h. Then, the supernatants were discarded, and 100 μL/well DMSO were added to dissolve the formazan crystals. The colored solutions were read by a microtiter plate spectrophotometer (BioTek Instruments, Winooski, VT, U.S.A.). Six replicates were used for each treatment. The experiments were repeated three times.
For the PI assay, HaCaT cells were incubated with 20 µg/mL of PI in 1× PBS, for 30 min at 20 °C. PI penetrates cells with altered membranes intercalating with the broken DNA, a typical process of cell necrosis. Samples were analyzed by a FACScan cytofluorimeter, using the CellQuest software. The experiments were repeated three times.
+ Open protocol
+ Expand
6

In Vitro Cytotoxicity Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
In vitro cytotoxicity was performed as previously described [13 (link),44 (link)], with slight modifications. Two cell lines were grown and maintained according to Ammerman et al. [45 (link)]: a Vero cell line (ECACC 88020401, African Green Monkey Kidney cells, GMK clone) and a 3T3 cell line (ECACC 86110401, mouse embryonic fibroblasts, A31 clone A31). The microtiter plates were incubated at 37 °C in 5% CO2 for 24 h. Vero and 3T3 cells were treated, for 20 h, with the crude extracts (1:1 in DMEM-Dulbecco’s Modified Eagle Medium). Four different concentrations of each crude extract were analysed (1, 0.5, 0.1 and 0.05 mg·mL−1 in phosphate buffered saline (PBS)). After the incubation period, the medium was removed by aspiration and 50 µL of DMEM with 10% resazurin (0.1 mg·mL−1 in PBS) was added to each well to assess cell viability. The microtiter plates were incubated at 37 °C in 5% CO2 during 3 h. The absorbance was read at 570 and 600 nm wavelengths in a microtiter plate spectrophotometer (Biotek Synergy, Portugal). PBS was used as control.
+ Open protocol
+ Expand
7

Cellular Viability Determination Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
For viability analysis, cells in the PFK15-treated and control groups were seeded into a 96-well plate at a density of 5,000–10,000 cells per well and allowed to adhere by culturing at 37°C overnight. For dose-dependent experiments, PFK15 was added in increasing concentrations (2, 4 and 6 μM) and incubated for 24 h. For time-dependent experiments, PFK15 (6 μM) or 3BP (25 μM) was added and incubated for 12, 24 or 48 h. For synergistic effect analysis, PFK15 (4 μM) combined with CQ (10 μM) or 3MA (1 mM) were added to the cells and incubated for 48 h. Subsequent to these different treatments, 0.8 mg/ml MTS was added to the samples and incubated for 3 h. The absorbance of samples were then read at 492nm using a microtiter plate spectrophotometer (BioTek Instruments, Inc., Winooski, VT, USA).
+ Open protocol
+ Expand
8

Cell Viability Assay for Cancer Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
T24 and 5637 BC and A498 RCC cells (8 × 104/mL) were plated in 96-well plates and treated for 24, 48 and 72 h with different doses of CPS (1–500 μM). At the end of the treatment, 0.8 mg/mL MTT was added to the samples and incubated for 3 h. The medium was removed from the wells, the formazan crystals were dissolved with 100 µL/well DMSO and the absorbance was read by a microtiter plate spectrophotometer (BioTek Instruments, Winooski, VT, USA). Four replicates were carried out for each treatment.
+ Open protocol
+ Expand
9

MTT Assay for Temozolomide Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three × 104/mL cells were plated in 96-well plates and treated with different doses of TMZ (125–500 μM), alone or in combination. After that, the samples were incubated for another 3 h with 0.8 mg/mL of MTT. A microtiter plate spectrophotometer (BioTek Instruments, Winooski, VT, USA) was used to measure the color of solutions after the formazan crystals had been dissolved with 100 μL of DMSO per well. Four replicates were used for each treatment. IC50 values correspond to the drug concentration that induces 50% of cell growth inhibition compared to control cells. IC50 values were calculated using GraphPad Prism® 5.0a (GraphPad Software, San Diego, CA, USA).
+ Open protocol
+ Expand
10

MTT Assay for Evaluating GBM Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
Three ×104/mL siTRPML1, siTRPML2 and siTRPML1/TRPML2 GBM cells were plated in 96-well plates for 24 h and 48 h post-transfection. Then, 0.8 mg/mL of MTT was added to the samples and incubated for an additional 3 h. After the removal of medium from the wells, the formazan crystals were dissolved with 100 µL per well of DMSO and the colored solutions were read by a microtiter plate spectrophotometer (BioTek Instruments, Winooski, VT, USA). Four replicates were used for each treatment.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!